通信電纜 網絡設備 無線通信 云計算|大數據 顯示設備 存儲設備 網絡輔助設備 信號傳輸處理 多媒體設備 廣播系統 智慧城市管理系統 其它智慧基建產品
北京方程嘉鴻科技有限公司
北京方程嘉鴻科技有限公司
北京方程生物公司經營銷售γ干擾素誘導蛋白16/p16（IFI16/p16）ELISA試劑盒，可以提供免費代測，送檢贈京東卡活動正在進行中，詳情咨詢銷售人員
C/EBPε
試劑盒名稱:γ干擾素誘導蛋白16/p16(IFI16/p16)ELISA試劑盒
英文名：Human CCAAT/enhancer binding protein epsilon,C/EBPε
品牌:BIOFINE
種屬:大鼠ELISA試劑盒
檢測波長:450nm
所需樣本體積: 50-100ul
適用范圍:僅供科研
保存及有效期:2-8℃，六個月，-20℃一年
檢測目的:用于測定血清，血漿及相關液體γ干擾素誘導蛋白16/p16(IFI16/p16)含量。適合檢測包括血清、血漿、尿液、胸腹水、灌洗液、腦脊液、細胞培養上清、組織勻漿等標本。
1.提供全程（售前，售后）提供技術指導，免除您實驗的后顧之憂。2.試劑盒*保障，有質量問題，免費包退換。3.提供免費代測服務，讓您省時省心。4.送貨上門，和各大快遞公司都有合作，保證發貨及時，運輸無憂。
γ干擾素誘導蛋白16/p16(IFI16/p16)contains the standard concentration of analyte will be prepared. Unknowns that generate a signal that is stronger than the known sample are "positive." Those that generate weaker signal are "negative." Doctor Dennis E Bidwell and Alister Voller created the test. History Before the development of the ELISA, the only option for conducting an immunoassay was radioimmunoassay, a technique using radioactively-labeled antigens or antibodies. In radioimmunoassay, the radioactivity provides the signal, which indicates whether a specific antigen or antibody is present in the sample. Radioimmunoassay was first described in a paper by Rosalyn Sussman Yalow and Solomon Berson published in 1960.[5] Because radioactivity poses a potential health threat, a safer alternative was sought. A suitable alternative to radioimmunoassay would substitute a non-radioactive signal in place of the radioactive signal. When enzymes (such as peroxidase) react with appropriate substrates (such as ABTS or 3,3’,5,5’-Tetramethylbenzidine), a change in color occurs, which is used as a signal. However, the signal has to be associated with the presence of antibody or antigen, which is why the enzyme has to be linked to an appropriate antibody. This linking process was independently developed by Stratis Avrameas and G.B. Pierce.[6] Since it is necessary to remove any unbound antibody or antigen by washing, the antibody or antigen has to be fixed to the surface of the container; i.e., the immunosorbent has to be prepared. A technique to accomplish this was published by Wide and Jerker Porath in 1966.[7] In 1971, Peter Perlmann and Eva Engvall at Stockholm University in Sweden, and Anton Schuurs and Bauke van Weemen in The Netherlands independently published papers that synthesized this knowledge into methods to perform EIA/ELISA.[8][9]
γ干擾素誘導蛋白16/p16(IFI16/p16)
表皮角蛋白(EK)
溶酶體相關膜蛋白2(HLAMP-2)
單純皰疹病毒抗原2(HSV-Ag2)
*(VD)
IPO-38蛋白(IPO38)
基質金屬蛋白酶抑制因子4(TIMP-4)
主要穹窿蛋白(MVP)
蛋白磷酸酶1調控/抑制因子亞基1A(PPP1R1A)
嗜酸性白血球相關之RNA水解酵素家族成員1(EAR1)
*乙酰化酶(CHAc)
生長激素結合蛋白(GHBP)
大腸癌專一抗原2(CCSA-2)
您感興趣的產品PRODUCTS YOU ARE INTERESTED IN
智慧城市網 設計制作，未經允許翻錄必究 .? ? ?
請輸入賬號
請輸入密碼
請輸驗證碼
